SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-15 Cr | ₹35 Cr | ₹8.29 Cr | ₹4.67 Cr | ₹-2.41 Cr |
What is the latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-15 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹8.29 Cr |
Mar2017 | ₹4.67 Cr |
Mar2016 | ₹-2.41 Cr |
How is Cash Flow from Financing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-15 Cr | Negative | |
Mar2023 | ₹35 Cr | 321.95 | |
Mar2022 | ₹8.29 Cr | 77.66 | |
Mar2017 | ₹4.67 Cr | Positive | |
Mar2016 | ₹-2.41 Cr | - |
Compare Cash Flow from Financing Activities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,951.4 Cr | -4.2% | 34.1% | 73.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -4.2% |
34.1% |
73.9% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses